Travere Therapeutics, Inc. (TVTX) insider trading.
In Q3 2026, insiders at Travere Therapeutics, Inc. reported 71 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 46 sales worth $67.0M.
- Transactions
- 71
- Purchases (P)
- 0
- Sales (S)
- 46
- Net shares, P minus S
- -1,060,936
- Insiders
- 9
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Heerma Peter | Officer · EVP, CHIEF COMMERCIAL OFFICER | 14 | 0 | 7 |
| Dube Eric M | Director, Officer · CHIEF EXECUTIVE OFFICER | 11 | 0 | 8 |
| Rote William E. | Officer · Chief Research Officer | 11 | 0 | 6 |
| Lyons Gary A | Director | 7 | 0 | 5 |
| Calvin Sandra | Officer · SVP, CHIEF ACCOUNTING OFFICER | 6 | 0 | 3 |
| Cline Christopher R. | Officer · CHIEF FINANCIAL OFFICER | 6 | 0 | 5 |
| Meckler Jeffrey A | Director | 6 | 0 | 4 |
| Reed Elizabeth E | Officer · Chief Legal Officer and GC | 5 | 0 | 4 |
| Inrig Jula | Officer · EVP, Head of R&D & CMO | 5 | 0 | 4 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Dube Eric M | S (D) | 6,802 | $64.95 | 432,886 | Form 4 |
| 2026-09-17 | Dube Eric M | M (A) | 108,493 | $23.34 | 541,379 | Form 4 |
| 2026-09-17 | Dube Eric M | S (D) | 101,691 | $64.59 | 439,688 | Form 4 |
| 2026-09-17 | Heerma Peter | M (A) | 8,282 | $22.4 | 125,348 | Form 4 |
| 2026-09-17 | Heerma Peter | S (D) | 8,282 | $65.07 | 117,066 | Form 4 |
| 2026-09-16 | Rote William E. | M (A) | 350 | $17.96 | 98,547 | Form 4 |
| 2026-09-16 | Rote William E. | M (A) | 55,000 | $15.46 | 153,547 | Form 4 |
| 2026-09-16 | Rote William E. | M (A) | 57,500 | $26.88 | 211,047 | Form 4 |
| 2026-09-16 | Rote William E. | S (D) | 65,104 | $63.12 | 145,943 | Form 4 |
| 2026-09-16 | Rote William E. | S (D) | 47,746 | $63.61 | 98,197 | Form 4 |
| 2026-09-16 | Dube Eric M | S (D) | 99,716 | $63.26 | 529,011 | Form 4 |
| 2026-09-16 | Dube Eric M | S (D) | 96,125 | $63.64 | 432,886 | Form 4 |
| 2026-09-16 | Dube Eric M | M (A) | 195,841 | $23.34 | 628,727 | Form 4 |
| 2026-09-16 | Heerma Peter | M (A) | 55,000 | $15.46 | 272,066 | Form 4 |
| 2026-09-16 | Heerma Peter | M (A) | 17,717 | $26.88 | 289,783 | Form 4 |
| 2026-09-16 | Heerma Peter | S (D) | 93,604 | $63.25 | 196,179 | Form 4 |
| 2026-09-16 | Heerma Peter | S (D) | 79,113 | $63.65 | 117,066 | Form 4 |
| 2026-09-16 | Heerma Peter | M (A) | 100,000 | $11.25 | 217,066 | Form 4 |
| 2026-09-15 | Reed Elizabeth E | S (D) | 1,400 | $63.69 | 105,689 | Form 4 |
| 2026-09-15 | Reed Elizabeth E | S (D) | 300 | $65.31 | 105,389 | Form 4 |
| 2026-09-15 | Reed Elizabeth E | S (D) | 13,874 | $62.63 | 107,089 | Form 4 |
| 2026-09-15 | Reed Elizabeth E | S (D) | 21,926 | $62.03 | 120,963 | Form 4 |
| 2026-09-15 | Reed Elizabeth E | M (A) | 37,500 | $15.46 | 142,889 | Form 4 |
| 2026-09-15 | Rote William E. | S (D) | 63,907 | $61.99 | 130,488 | Form 4 |
| 2026-09-15 | Rote William E. | S (D) | 29,021 | $62.66 | 101,467 | Form 4 |
| 2026-09-15 | Rote William E. | S (D) | 3,000 | $63.65 | 98,467 | Form 4 |
| 2026-09-15 | Rote William E. | S (D) | 270 | $65.31 | 98,197 | Form 4 |
| 2026-09-15 | Rote William E. | M (A) | 39,000 | $25.25 | 154,745 | Form 4 |
| 2026-09-15 | Rote William E. | M (A) | 39,650 | $17.96 | 194,395 | Form 4 |
| 2026-09-15 | Dube Eric M | M (A) | 95,666 | $23.34 | 528,552 | Form 4 |
| 2026-09-15 | Dube Eric M | S (D) | 63,498 | $61.99 | 465,054 | Form 4 |
| 2026-09-15 | Dube Eric M | S (D) | 28,796 | $62.66 | 436,258 | Form 4 |
| 2026-09-15 | Dube Eric M | S (D) | 3,102 | $63.64 | 433,156 | Form 4 |
| 2026-09-15 | Dube Eric M | S (D) | 270 | $65.31 | 432,886 | Form 4 |
| 2026-09-15 | Heerma Peter | S (D) | 1,431 | $65.31 | 117,066 | Form 4 |
| 2026-09-15 | Heerma Peter | S (D) | 1,400 | $63.65 | 118,497 | Form 4 |
| 2026-09-15 | Heerma Peter | S (D) | 27,421 | $62.59 | 119,897 | Form 4 |
| 2026-09-15 | Heerma Peter | S (D) | 71,938 | $62.05 | 147,318 | Form 4 |
| 2026-09-15 | Heerma Peter | M (A) | 36,526 | $8.93 | 219,256 | Form 4 |
| 2026-09-15 | Heerma Peter | M (A) | 1,381 | $22.4 | 182,730 | Form 4 |
| 2026-09-15 | Heerma Peter | M (A) | 39,283 | $26.88 | 181,349 | Form 4 |
| 2026-09-15 | Calvin Sandra | M (A) | 2,500 | $27.5 | 44,853 | Form 4 |
| 2026-09-15 | Calvin Sandra | M (A) | 1,250 | $22.4 | 46,103 | Form 4 |
| 2026-09-15 | Calvin Sandra | S (D) | 300 | $63.66 | 42,353 | Form 4 |
| 2026-09-15 | Calvin Sandra | S (D) | 4,275 | $62.14 | 43,453 | Form 4 |
| 2026-09-15 | Calvin Sandra | S (D) | 800 | $62.85 | 42,653 | Form 4 |
| 2026-09-15 | Calvin Sandra | M (A) | 1,625 | $20.46 | 47,728 | Form 4 |
| 2026-09-15 | Inrig Jula | M (A) | 32,395 | $8.93 | 145,165 | Form 4 |
| 2026-09-15 | Inrig Jula | S (D) | 25,390 | $62.02 | 119,775 | Form 4 |
| 2026-09-15 | Inrig Jula | S (D) | 400 | $65.31 | 100,491 | Form 4 |
| 2026-09-15 | Inrig Jula | S (D) | 1,600 | $63.69 | 100,891 | Form 4 |
| 2026-09-15 | Inrig Jula | S (D) | 17,284 | $62.62 | 102,491 | Form 4 |
| 2026-09-15 | Cline Christopher R. | S (D) | 27,473 | $62 | 110,543 | Form 4 |
| 2026-09-15 | Cline Christopher R. | M (A) | 20,000 | $17.44 | 138,016 | Form 4 |
| 2026-09-15 | Cline Christopher R. | S (D) | 400 | $65.31 | 87,508 | Form 4 |
| 2026-09-15 | Cline Christopher R. | S (D) | 20,735 | $62.61 | 89,808 | Form 4 |
| 2026-09-15 | Cline Christopher R. | S (D) | 1,900 | $63.69 | 87,908 | Form 4 |
| 2026-09-10 | Meckler Jeffrey A | S (D) | 3,100 | $68.09 | 91,500 | Form 4 |
| 2026-09-10 | Meckler Jeffrey A | S (D) | 14,000 | $67.46 | 94,600 | Form 4 |
| 2026-09-10 | Meckler Jeffrey A | S (D) | 1,200 | $66.15 | 108,600 | Form 4 |
| 2026-09-10 | Meckler Jeffrey A | M (A) | 10,000 | $26.52 | 111,500 | Form 4 |
| 2026-09-10 | Meckler Jeffrey A | M (A) | 10,000 | $17.44 | 101,500 | Form 4 |
| 2026-09-10 | Meckler Jeffrey A | S (D) | 1,700 | $65.39 | 109,800 | Form 4 |
| 2026-09-02 | Cline Christopher R. | S (D) | 642 | $66.37 | 118,016 | Form 4 |
| 2026-08-18 | Lyons Gary A | M (A) | 5,000 | $17.44 | 66,500 | Form 4 |
| 2026-08-18 | Lyons Gary A | S (D) | 900 | $63.86 | 61,500 | Form 4 |
| 2026-08-18 | Lyons Gary A | S (D) | 4,100 | $63.27 | 62,400 | Form 4 |
| 2026-08-17 | Lyons Gary A | M (A) | 5,000 | $17.44 | 66,500 | Form 4 |
| 2026-08-17 | Lyons Gary A | S (D) | 1,900 | $62.53 | 64,600 | Form 4 |
| 2026-08-17 | Lyons Gary A | S (D) | 2,600 | $63.5 | 62,000 | Form 4 |
| 2026-08-17 | Lyons Gary A | S (D) | 500 | $64.16 | 61,500 | Form 4 |
Transaction codes in this quarter
Get TVTX insider transactions through the API
Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1438533&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TVTX company page · Travere Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Travere Therapeutics, Inc. (TVTX)?
In Q3 2026, insiders at Travere Therapeutics, Inc. reported 71 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 46 sales worth $67.0M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Travere Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.
Plain-text version for agents and LLMs: /insider-trading/tvtx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.